Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Hepatol. 2019 Oct 10;72(3):391–400. doi: 10.1016/j.jhep.2019.09.029

Table 1:

Logistic regression analysis of clinical parameters associated with Candidalysin

Candidalysin Negative Positive OR, (95% CI, P value)
MELD 24 (5.5) 27.8 (7.7) 1.09 (1.02–1.18, P=0.017)
Antibiotic use 14 (23.0) 10 (35.7) 1.87 (0.69–4.96, P=0.211)
Steroids 23 (37.7) 10 (35.7) 0.92 (0.35–2.30, P=0.857)

Data in second and third column presented as mean (SD) or n (%). Bold font indicates significance (P value <0.05). All variables shown in Supplementary Table S1 and S2 were included in the logistic regression analysis. Shown are only the most relevant.

OR, odds ratio; CI, confidence interval; MELD, Model for End-stage Liver Disease.

HHS Vulnerability Disclosure